Q32 Bio Inc.（QTTB）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Q32 Bio Inc.（QTTB）报告了 26 笔 Form 4 交易（最近一笔 2026-08-27）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-27 | Morrison Jodie Pope | CEO | 卖出 | 9,845 | $163,033 |
| 2026-08-27 | Kalowski Lee | CFO and President | 卖出 | 3,972 | $65,776 |
| 2026-08-27 | Violette Shelia M. | Chief Scientific Officer | 卖出 | 2,798 | $46,335 |
| 2026-07-20 | Morrison Jodie Pope | CEO | 买入 | 132,000 | $0 |
| 2026-07-20 | Kalowski Lee | CFO and President | 买入 | 53,250 | $0 |
| 2026-07-20 | Violette Shelia M. | Chief Scientific Officer | 买入 | 37,500 | $0 |
| 2026-07-02 | Manke Isaac | 董事 | 买入 | 53,521 | $149,859 |
| 2026-06-01 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 625,000 | $5.0M |
| 2026-06-01 | Xu Diyong | 董事 | 买入 | 625,000 | $5.0M |
| 2026-06-01 | ORBIMED ADVISORS LLC | 董事 | 买入 | 1.2M | $10.0M |
| 2026-06-01 | OrbiMed Capital GP VII LLC | 董事 | 买入 | 1.2M | $10.0M |
| 2026-06-01 | OrbiMed Genesis GP LLC | 董事 | 买入 | 1.2M | $10.0M |
| 2026-06-01 | ORBIMED ADVISORS LLC | 董事 | 买入 | 625,000 | $5.0M |
| 2026-06-01 | Xu Diyong | 董事 | 买入 | 1.2M | $10.0M |
| 2026-06-01 | OrbiMed Genesis GP LLC | 董事 | 买入 | 625,000 | $5.0M |
| 2026-03-20 | Violette Shelia M. | Chief Scientific Officer | 买入 | 37,500 | $0 |
| 2026-03-20 | Morrison Jodie Pope | CEO | 买入 | 132,000 | $0 |
| 2026-03-20 | Kalowski Lee | CFO and President | 买入 | 53,250 | $0 |
| 2026-02-27 | Morrison Jodie Pope | CEO | 卖出 | 9,896 | $44,631 |
| 2026-02-27 | Kalowski Lee | CFO and President | 卖出 | 3,995 | $18,017 |
| 2026-02-27 | Violette Shelia M. | Chief Scientific Officer | 卖出 | 2,815 | $12,696 |
| 2025-12-04 | Kalowski Lee | CFO and President | 卖出 | 9,072 | $31,389 |
| 2025-12-04 | Morrison Jodie Pope | CEO | 卖出 | 22,506 | $77,871 |
| 2025-08-28 | Morrison Jodie Pope | CEO | 卖出 | 10,494 | $18,889 |
| 2025-08-28 | Violette Shelia M. | Chief Scientific Officer | 卖出 | 2,990 | $5,382 |
来源：SEC Form 4 申报文件 · 截至 2026-08-27